The Biological Hourglass Hidden in Our DNA

Matteo Gizzi 23 Set 2025


At the end of every chromosome, like the plastic tips on the ends of a shoelace, are the telomeres: repetitive DNA sequences with a fundamental protective function. Each time a cell divides to regenerate our tissues, these caps shorten slightly. It is an inevitable process, a kind of "tax" on replication. When, after many divisions, the telomeres become too short, the cell receives a stop signal: it stops dividing and enters a state of senescence, or it triggers programmed cell death (apoptosis). This process, which at an individual level protects against cancer, contributes significantly to aging and the onset of age-related diseases on the scale of the entire organism. Understanding this mechanism has transformed telomeres from a simple molecular curiosity into a primary target for a new generation of anti-aging drugs.

The Enzyme of Eternal Youth: Telomerase
Nature, however, has provided a maintenance mechanism: telomerase, an enzyme capable of restoring telomere length by adding new repeated sequences to the ends of chromosomes. This enzyme is very active in stem and germ cells, ensuring their ability to replicate for a long time, but it is almost silent in most adult cells in our body. The great challenge of longevity medicine has therefore become: is it possible to safely reactivate telomerase in somatic cells to slow down, or even reverse, the cellular aging clock?

"Telomeres are our body's biological timer," explains Prof. Fabrizio d’Adda di Fagagna, a cell biologist heading a research unit at IFOM. "Their state reflects not just chronological age, but the real health of our cells. When they get damaged, they activate perennial molecular alarm signals that drive aging."

The Integration of Scientific Studies: From Nature to Nanotechnology
The search for "telomerase activators" is in full swing and is following diverse and complementary paths, from the plant world to RNA therapies.

One of the most recent and promising studies, conducted by the University of Padua, has demonstrated the effectiveness of a natural extract from the plant Monarda didyma. In a clinical trial with 81 people, participants who took the extract for three months showed a significant improvement in the telomere length of their white blood cells and a stabilization of their epigenetic age (another key marker of aging), unlike the placebo group, which experienced telomere shortening. This study is important because it validates the "gentle" approach of natural supplements in modulating the fundamental mechanisms of aging.

In parallel, research is pushing to a much higher level of molecular precision. Prof. d'Adda di Fagagna's lab is focusing not so much on activating telomerase, but on "switching off" the damage signals that come from short telomeres. They discovered that damaged telomeres produce specific RNA fragments (called DDRNA) that fuel inflammation and senescence. Based on this discovery, they are developing antisense RNA molecules designed to selectively bind to and neutralize these alarm signals. This approach, which has already shown promise in treating models of accelerated aging diseases like progeria, represents a therapeutic strategy of the highest precision.

Finally, a discovery described as "unexpected" and published in Nature Cell Biology has revealed a completely new mechanism: the transfer of telomeres between cells. A research team observed that immune system cells can "donate" pieces of their telomeres to other cells through tiny vesicles, effectively "rejuvenating" the receiving cells. This discovery not only explains how the immune system can maintain its longevity but also opens the way for revolutionary therapies: in the future, these vesicles, isolated from blood and purified, could be used as a true anti-aging drug to "recharge" the telomeres of senescent cells.

The Other Side of the Coin: The Oncological Risk
The biggest challenge and controversy related to telomerase activation is the oncological risk. Cancer cells, in order to proliferate uncontrollably, forcefully reactivate telomerase to become immortal. The indiscriminate activation of this enzyme throughout the body could, in theory, promote the growth of latent tumors. For this reason, research is proceeding with extreme caution, developing activators that act transiently or are targeted only to specific cell types, and rigorously monitoring the long-term safety of each approach.

Towards a Medicine of Longevity
Understanding the telomere code is shifting the axis of medicine. Instead of treating individual age-related diseases (cancers, cardiovascular pathologies, neurodegenerative disorders), the focus is now on their common denominator: cellular aging. The goal is not immortality, but the increase of "healthspan," the duration of life spent in good health. By combining telomere-targeted therapies with digital biomarkers and artificial intelligence to monitor biological age in real-time, science is building the tools for a truly preventive and personalized medicine, with the promise not only of adding years to life, but more importantly, life to years

 

Ultima modifica il Lunedì, 22 Settembre 2025 11:42
Vota questo articolo
(0 Voti)

Lascia un commento

Assicurati di aver digitato tutte le informazioni richieste, evidenziate da un asterisco (*). Non è consentito codice HTML.

 

Scienzaonline con sottotitolo Sciencenew  - Periodico
Autorizzazioni del Tribunale di Roma – diffusioni:
telematica quotidiana 229/2006 del 08/06/2006
mensile per mezzo stampa 293/2003 del 07/07/2003
Scienceonline, Autorizzazione del Tribunale di Roma 228/2006 del 29/05/06
Pubblicato a Roma – Via A. De Viti de Marco, 50 – Direttore Responsabile Guido Donati

Photo Gallery